Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Verve Therapeutics SG&A Expenses 2020-2024 | VERV

Verve Therapeutics sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  
Verve Therapeutics Annual SG&A Expenses
(Millions of US $)
2023 $50
2022 $38
2021 $19
2020 $5
2019 $2
Verve Therapeutics Quarterly SG&A Expenses
(Millions of US $)
2024-03-31 $14
2023-12-31 $12
2023-09-30 $12
2023-06-30 $13
2023-03-31 $13
2022-12-31 $11
2022-09-30 $10
2022-06-30 $9
2022-03-31 $7
2021-12-31 $7
2021-09-30 $6
2021-06-30 $4
2021-03-31 $3
2020-12-31
2020-09-30 $1
2020-06-30 $1
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.510B $0.012B
Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's lead product candidate includes VERVE-101. Verve Therapeutics is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.252B 30.60
Chugai Pharmaceutical (CHGCY) Japan $52.146B 23.31
Takeda Pharmaceutical (TAK) Japan $41.333B 6.70
Merck (MKGAF) Germany $21.344B 20.14
Astellas Pharma (ALPMY) Japan $17.961B 28.36
Sandoz Group AG (SDZNY) Switzerland $14.913B 0.00
Shionogi (SGIOY) Japan $14.127B 12.67
Neurocrine Biosciences (NBIX) United States $13.991B 38.30
United Therapeutics (UTHR) United States $11.581B 12.35
Catalent (CTLT) United States $10.171B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.637B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.978B 7.67
Revolution Medicines (RVMD) United States $6.532B 0.00
Ionis Pharmaceuticals (IONS) United States $5.862B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.434B 0.00
Alpine Immune Sciences (ALPN) United States $4.242B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.007B 0.00
Summit Therapeutics (SMMT) United States $3.482B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.125B 0.00
Corcept Therapeutics (CORT) United States $2.644B 23.96
Indivior (INDV) United States $2.451B 11.62
PTC Therapeutics (PTCT) United States $2.388B 0.00
Dyne Therapeutics (DYN) United States $2.245B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.023B 11.56
Recursion Pharmaceuticals (RXRX) United States $2.016B 0.00
Ardelyx (ARDX) United States $1.973B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.945B 0.00
Evotec AG (EVO) Germany $1.839B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.820B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.737B 16.92
Taro Pharmaceutical Industries (TARO) Israel $1.589B 27.82
Soleno Therapeutics (SLNO) United States $1.546B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.472B 0.00
Xencor (XNCR) United States $1.459B 0.00
Pacira BioSciences (PCRX) United States $1.380B 13.12
4D Molecular Therapeutics (FDMT) United States $1.347B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.271B 11.94
Collegium Pharmaceutical (COLL) United States $1.245B 7.66
Enliven Therapeutics (ELVN) United States $1.151B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.053B 0.00
Cronos Group (CRON) Canada $0.986B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.955B 0.00
Cassava Sciences (SAVA) United States $0.933B 0.00
Ocular Therapeutix (OCUL) United States $0.891B 0.00
ARS Pharmaceuticals (SPRY) United States $0.878B 0.00
Relay Therapeutics (RLAY) United States $0.864B 0.00
USANA Health Sciences (USNA) United States $0.858B 14.02
Sage Therapeutics (SAGE) United States $0.746B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.735B 0.00
Savara (SVRA) United States $0.690B 0.00
Silence Therapeutics (SLN) United Kingdom $0.676B 0.00
Lyell Immunopharma (LYEL) United States $0.637B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.613B 0.00
Exscientia (EXAI) United Kingdom $0.566B 0.00
ProKidney (PROK) United States $0.555B 0.00
Siga Technologies (SIGA) United States $0.533B 6.82
OmniAb (OABI) United States $0.532B 0.00
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Altimmune (ALT) United States $0.508B 0.00
Larimar Therapeutics (LRMR) United States $0.505B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.461B 0.00
Heron Therapeutics (HRTX) United States $0.453B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.453B 0.00
Lexeo Therapeutics (LXEO) United States $0.452B 0.00
Korro Bio (KRRO) United States $0.420B 0.00
Bioventus (BVS) United States $0.399B 15.27
Tourmaline Bio (TRML) United States $0.399B 0.00
Esperion Therapeutics (ESPR) United States $0.387B 0.00
Harrow (HROW) United States $0.365B 0.00
Black Diamond Therapeutics (BDTX) United States $0.365B 0.00
Nanobiotix S.A (NBTX) France $0.325B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.323B 0.00
Organogenesis (ORGO) United States $0.305B 57.75
Nektar Therapeutics (NKTR) United States $0.301B 0.00
ESSA Pharma (EPIX) Canada $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 18.76
Akebia Therapeutics (AKBA) United States $0.293B 0.00
Fractyl Health (GUTS) United States $0.290B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Xeris Biopharma Holdings (XERS) United States $0.274B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.270B 0.00
Eliem Therapeutics (ELYM) United States $0.258B 0.00
Metagenomi (MGX) United States $0.255B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Adherex Technologies (FENC) United States $0.253B 0.00
Pyxis Oncology (PYXS) United States $0.251B 0.00
Aldeyra Therapeutics (ALDX) United States $0.242B 0.00
Avita Medical (RCEL) United States $0.231B 0.00
Zevra Therapeutics (ZVRA) United States $0.224B 0.00
Conduit Pharmaceuticals (CDT) United States $0.218B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
Century Therapeutics (IPSC) United States $0.199B 0.00
Acrivon Therapeutics (ACRV) United States $0.186B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Telomir Pharmaceuticals (TELO) United States $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.174B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Incannex Healthcare (IXHL) Australia $0.156B 0.00
CytoDyn (CYDY) United States $0.153B 0.00
Prelude Therapeutics (PRLD) United States $0.151B 0.00
Regulus Therapeutics (RGLS) United States $0.149B 0.00
Elite Pharmaceuticals (ELTP) United States $0.141B 13.20
Cardiol Therapeutics (CRDL) Canada $0.137B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.131B 2.76
VAXART, INC (VXRT) United States $0.129B 0.00
Inotiv (NOTV) United States $0.123B 0.00
Karyopharm Therapeutics (KPTI) United States $0.119B 0.00
OptiNose (OPTN) United States $0.118B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
FibroGen (FGEN) United States $0.112B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Citius Pharmaceuticals (CTXR) United States $0.106B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.59
ProPhase Labs (PRPH) United States $0.097B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
AlloVir (ALVR) United States $0.090B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.079B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Jaguar Animal Health (JAGX) United States $0.074B 0.00
Journey Medical (DERM) United States $0.071B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.98
Champions Oncology (CSBR) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Carisma Therapeutics (CARM) United States $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.061B 0.00
BioLineRx (BLRX) Israel $0.053B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
JanOne (JAN) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Protara Therapeutics (TARA) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
DURECT (DRRX) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Nutriband (NTRB) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Lyra Therapeutics (LYRA) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.06
PolyPid (PYPD) Israel $0.021B 0.00
BioVie (BIVI) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
CERo Therapeutics Holdings (CERO) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Aptorum Group (APM) United Kingdom $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Acutus Medical (AFIB) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.23
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.40